Centre Hospitalier de l'Universite de Quebec
Prognostic significance of lymphovascular invasion assessed
Published in Surgery Litigation and Law Weekly, July 15th, 2005
"Surgery is considered curative in Dukes' B rectal cancer; however, many patients present with early relapse. To identify additional staging information, venous and lymphatic invasion were evaluated as potential prognostic factors," scientists in Canada reported.
"Patients with Dukes' B or C rectal disease treated between 1976 and 2001 at a single institution were compared. Patient and treatment characteristics and vascular invasion were documented. The impact of vessel invasion was determined using Cox proportional hazards model,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Cleveland Clinic Foundation
Adjuvant and neoadjuvant chemotherapy for bladder cancer studied - EDAP TMS S.A.
Ablatherm HIFU a safe alternative to surgery or radiotherapy - FoxHollow Technologies, Inc.
One-year outcomes data on plaque excision released at vascular surgery meeting - Hannover Medical School
Accuracy of CT-based bone drilling navigation evaluated - National Cancer Center, Singapore
Acceptance of prophylactic surgery and chemoprevention surveyed in Singapore - University of Birmingham
Gene- and immunotherapy for hepatocellular carcinoma reviewed - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
